Skip to main content
Lipocine Inc. logo

Lipocine Inc. — Investor Relations & Filings

Ticker · LPCN ISIN · US53630X1046 LEI · 549300RXPEQXOJXVBI10 US Manufacturing
Open in API
Filings indexed 786 across all filing types
Latest filing 2018-09-20 Capital/Financing Update
Country US United States of America
Listing US LPCN

About Lipocine Inc.

https://www.lipocine.com/

Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.

Recent filings

Filing Released Lang Actions
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a controlled equity offering and sales agreement for common stock. It discusses registration of shares for sale, offering price, and references a prior prospectus and registration statement. The content is focused on capital raising and securities offering details, not on financial results, management changes, or other report types. The document length is 3432 characters, which is relatively short but contains substantive offering details rather than just an announcement. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities.
2018-09-20 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions that the company has prepared a presentation (LPCN 1144 Presentation) used for investor meetings and that this presentation is filed as an exhibit. The document itself is short (2812 characters) and primarily serves to announce the filing of an investor presentation rather than containing the presentation content or detailed financial data. According to the classification rules, such a document is best classified as an Investor Presentation (IP) because it references and files a presentation intended for investors and analysts. The Form 8-K is not a full financial report, earnings release, or regulatory filing of a different nature, and it is not merely an announcement of a report publication. Therefore, the most appropriate classification is Investor Presentation (IP).
2018-08-29 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The specific content of this 8-K is the resignation of an executive officer, Gregory Bass, including the effective date and the absence of financial commitments related to the resignation. This corresponds to an announcement of changes in senior management. The document is short (2840 characters) and focuses solely on management changes, not on financial results or other report types. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-08-17 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock and incentive plans. It includes details about the securities to be registered, references to prior filings, indemnification provisions, and exhibits related to the stock plan. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. The document is lengthy (15,000 characters) and contains the full registration statement, not just an announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2018-08-08 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text indicates that the company updated its corporate presentation and issued a press release announcing financial and operational results for the second quarter and six months ended June 30, 2018. The document itself does not contain the full financial results but references exhibits including a corporate presentation and a press release. The length of the document is 3119 characters, which is relatively short and mainly serves as an announcement of these materials rather than containing the full reports. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain substantive financial data or the full report itself.
2018-08-07 English
10-Q
Interim / Quarterly Report Q2 2018
2018-08-07 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.